Managing Collapsed or Seriously Ill Participants of Ultra-Endurance Events in Remote Environments

Sports Medicine

Volumn 45, Issue 2, 2015, Pages 201-212

  Hoffman, Martin D ^a,g   Rogers, Ian R ^b   Joslin, Jeremy ^c   Asplund, Chad A ^d   Roberts, William O ^e   Levine, Benjamin D ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b St John of God Dermatology   (Australia)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETIC INJURIES; COMPETITIVE BEHAVIOR; EMERGENCY HEALTH SERVICE; EMERGENCY TREATMENT; ENDURANCE; ENVIRONMENT; HUMAN; PHYSIOLOGY; RUNNING;

ATHLETIC INJURIES; COMPETITIVE BEHAVIOR; EMERGENCY TREATMENT; ENVIRONMENT; HUMANS; PHYSICAL ENDURANCE; RUNNING; TRIAGE;

EID: 84930181923     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-014-0270-y     Document Type: Review

References (78)

1. Cejka N, Rüst CA, Lepers R, et al. Participation and performance trends in 100-km ultra-marathons worldwide. J Sports Sci. 2014;32:354–66.
2. Hoffman MD, Ong JC, Wang G. Historical analysis of participation in 161 km ultramarathons in North America. Int J Hist Sport. 2010;27:1877–91.
3. Ultrarunning—the year in review. Ultrarunning. 2014:30–47.
4. Bishop GW, Fallon KE. Musculoskeletal injuries in a 6-day track race: ultramarathoner’s ankle. Clin J Sport Med. 1999;9:216–20.
5. Fallon KE. Musculoskeletal injuries in the ultramarathon: the 1990 Westfield Sydney to Melbourne run. Br J Sports Med. 1996;30:319–23.
6. Graham SM, McKinley M, Chris CC, et al. Injury occurrence and mood states during a desert ultramarathon. Clin J Sports Med. 2012;0:1–5.
7. Hoffman MD, Pasternak A, Rogers IR, et al. Consensus guidelines for medical services at ultra-endurance foot races in remote environments. Sports Med. 2014;44:1055–69.
8. Holtzhausen LM, Noakes TD. Collapsed ultraendurance athlete: proposed mechanisms and an approach to management. Clin J Sport Med. 1997;7:292–301.
9. Khodaee M, Ansari M. Common ultramarathon injuries and illnesses: race day management. Curr Sports Med Rep. 2012;11:290–7.
10. Krabak BJ, Waite B, Schiff MA. Study of injury and illness rates in multiday ultramarathon runners. Med Sci Sports Exerc. 2011;43:2314–20.
11. Laird RH. Medical care at ultraendurance triathlons. Med Sci Sports Exerc. 1989;21(5 Suppl):S222–5.
12. McGowan V, Hoffman MD. Characterization of medical care at the 161-km Western States Endurance Run. Wildernes Environ Med. 2014. doi:10.1016/j.wem.2014.06.015 [Epub ahead of print].
13. McLaughlin KA, Townes DA, Wedmore IS, et al. Pattern of injury and illness during expedition-length adventure races. Wilderness Environ Med. 2006;17:158–61.
14. Reid SA, King MJ. Serum biochemistry and morbidity among runners presenting for medical care after an Australian mountain ultramarathon. Clin J Sport Med. 2007;17:307–10.
15. Scheer BV, Murray A. Al Andalus ultra trail: an observation of medical interventions during a 219-km, 5-day ultramarathon stage race. Clin J Sport Med. 2011;21:444–6.
16. Schwabe K, Schwellnus M, Derman W, et al. Medical complications and deaths in 21 and 56 km road race runners: a 4-year prospective study in 65,865 runners—SAFER study I. Br J Sports Med. 2014;48(11):912–8.
17. Speedy DB, Rogers IR, Noakes TD, et al. Diagnosis and prevention of hyponatremia at an ultradistance triathlon. Clin J Sport Med. 2000;10:52–8.
18. Townes DA, Talbot TS, Wedmore IS, et al. Event medicine: injury and illness during an expedition-length adventure race. J Emerg Med. 2004;27:161–5.
19. Asplund CA, O’Connor FG, Noakes TD. Exercise-associated collapse: an evidence-based review and primer for clinicians. Br J Sports Med. 2011;45:1157–62.
20. Brennan FH, O’Connor FG. Emergency triage of collapsed endurance athletes: a stepwise approach to on-site treatment. Phys Sportsmed. 2005;33:28–35.
21. Childress MA, O’Connor FG, Levine BD. Exertional collapse in the runner: evaluation and management in fieldside and office-based settings. Clin Sports Med. 2010;29:459–76.
22. Lento PH, Sullivan WJ. The downed runner. Phys Med Rehabil Clin N Am. 2005;16:831–49.
23. Roberts WO. Exercise-associated collapse care matrix in the marathon. Sports Med. 2007;37:431–3.
24. Speedy DB, Noakes TD, Holtzhausen LM. Exercise-associated collapse: postural hypotension, or something deadlier? Phys Sportsmed. 2003;31:23–9.
25. Bennett BL, Hew-Butler T, Hoffman MD, et al. Wilderness Medical Society practice guidelines for treatment of exercise-associated hyponatremia. Wilderness Environ Med. 2013;24:228–40.
26. Burdick TE. Wilderness event medicine: planning for mass gatherings in remote areas. Travel Med Infect Dis. 2005;3:249–58.
27. Paal P, Milani M, Brown D, et al. Termination of cardiopulmonary resuscitation in mountain rescue. High Alt Med Biol. 2012;13:200–8.
28. Wright JM, Islas AA. Concussion management in the wilderness. Wilderness Environ Med. 2014;25:319–24.
29. Dunn L. Raised intracranial pressure. J Neurol Neurosurg Psychiatry. 2002;73(Suppl 1):i23–7.
30. Quinn R, Williams J, Bennett B, et al. Wilderness Medical Society practice guidelines for spine immobilization in the austere environment. Wilderness Environ Med. 2013;24:241–52.
31. Roberts WO. A 12-year profile of medical injury and illness for the Twin Cities Marathon. Med Sci Sports Exerc. 2000;32:1549–55.
32. Roberts WO. Exercise-associated collapse in endurance events: a classification system. Phys Sportsmed. 1989;17:49–55.
33. Holtzhausen LM, Noakes TD. The prevalence and significance of post-exercise (postural) hypotension in ultramarathon runners. Med Sci Sports Exerc. 1995;27:1595–601.
34. Holtzhausen LM, Noakes TD, Kroning B, et al. Clinical and biochemical characteristics of collapsed ultra-marathon runners. Med Sci Sports Exerc. 1994;26:1095–101.
35. Hastings JL, Levine BD. Syncope in the athletic patient. Prog Cardiovasc Dis. 2001;54:438–44.
36. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;332:349–60.
37. Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias—executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42:1493–531.
38. Smith G, Morgans A, Boyle M. Use of the Valsalva manoeuvre in the prehospital setting: a review of the literature. Emerg Med J. 2009;26:8–10.
39. Shapiro SY, Seidman DS. Field and clinical observations of exertional heat stroke patients. Med Sci Sport Exerc. 1990;22:6–14.
40. Vicario SJ, Okabajue R, Haltom T. Rapid cooling in classic heatstroke: effect on mortality rates. Am J Emerg Med. 1986;4:394–8.
41. Smith JE. Cooling methods used in the treatment of exertional heat illness. Br J Sports Med. 2005;39:503–7.
42. Casa DJ, McDermott BP, Lee EC, et al. Cold water immersion: the gold standard for exertional heatstroke treatment. Exerc Sport Sci Rev. 2007;35:141–9.
43. Lipman GS, Eifling KP, Ellis MA, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of heat-related illness. Wilderness Environ Med. 2013;24:351–61.
44. Brown DJA, Brugger H, Boyd J, et al. Accidental hypothermia. N Engl J Med. 2012;367:1930–8.
45. Giesbrecht GG. Emergency treatment of hypothermia. Emerg Med (Australas). 2001;13:9–16.
46. Grueskin J, Tanen DA, Harvey P, et al. A pilot study of mechanical stimulation and cardiac dysrhythmias in a porcine model of induced hypothermia. Wilderness Environ Med. 2007;18:133–7.
47. Lumb AN, Gallen IW. Diabetes management for intense exercise. Curr Opin Endocrinol Diabetes Obes. 2009;16:150–5.
48. Graveling AJ, Frier BM. Risks of marathon running and hypoglycaemia in type 1 diabetes. Diabet Med. 2010;27:585–8.
49. Baska RS, Moses FM, Graeber G, et al. Gastrointestinal bleeding during an ultramarathon. Dig Dis Sci. 1990;35:276–9.
50. Glace B, Murphy C, McHugh M. Food and fluid intake and disturbances in gastrointestinal and mental function during an ultramarathon. Int J Sport Nutr Exerc Metab. 2002;12:414–27.
51. Glace BW, Murphy CA, McHugh MP. Food intake and electrolyte status of ultramarathoners competing in extreme heat. J Am Coll Nutr. 2002;21(6):553–9.
52. Hoffman MD, Fogard K. Factors related to successful completion of a 161-km ultramarathon. Int J Sports Physiol Perform. 2011;6:25–37.
53. Stuempfle KJ, Hoffman MD, Hew-Butler T. Association of gastrointestinal distress in ultramarathoners with race diet. Int J Sport Nutr Exerc Metabol. 2013;23:103–9.
54. Attvall S, Lager I, Smith U. Rectal glucose administration cannot be used to treat hypoglycemia. Diabetes Care. 1985;8:412–3.
55. Vukmir RB, Paris PM, Yealy DM. Glucagon: prehospital therapy for hypoglycemia. Ann Emerg Med. 1991;20:375–9.
56. Hew-Butler T, Ayus JC, Kipps C, et al. Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med. 2008;18:111–21.
57. Bennett BL, Hew-Butler T, Hoffman MD, et al. In reply to clinical practice guidelines for treatment of exercise-associated hyponatremia. Wilderness Environ Med. 2013;24:468–71.
58. Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med. 2000;132:711–4.
59. Frizzell RT, Lang GH, Lowance DC, et al. Hyponatremia and ultramarathon running. JAMA. 1986;255:772–4.
60. Hoffman MD, Stuempfle KJ, Sullivan K, et al. Exericise-associated hyponatremia with exertional rhabdomyolysis: importance of proper treatment. Clin Nephrol. 2014. [Epub ahead of print].
61. Siegel AJ, d’Hemecourt P, Adner MM, et al. Exertional dysnatremia in collapsed marathon runners: a critical role for point-of-care testing to guide appropriate therapy. Am J Clin Path. 2009;132(3):336–40.
62. Elsaesser TF, Pang PS, Malik S, et al. Large-volume hypertonic saline therapy in endurance athlete with exercise-associated hyponatremic encephalopathy. J Emerg Med. 2013;44:1132–5.
63. Hoffman MD, Hew-Butler T, Schwellnus M. Regarding the Wilderness Medical Society practice guidelines for heat-related illness. Wilderness Environ Med. 2014;25(2):246–7.
64. Hoffman MD, Weiss RH. Symptomatic hypotonic hyponatremia presenting at high altitude. Wilderness Environ Med. 2014. [Epub ahead of print].
65. Noakes TD. Hyponatremia in distance athletes: pulling the IV on the ‘dehydration myth’. Phys Sportsmed. 2000;28:71–6.
66. Pyne S. Intravenousfluids post marathon: when and why? Sports Med. 2007;37:434–6.
67. Hoffman MD, Hew-Butler T, Stuempfle KJ. Exercise-associated hyponatremia and hydration status in 161-km ultramarathoners. Med Sci Sports Exerc. 2013;45:784–91.
68. Noakes TD, Sharwood K, Speedy D, et al. Three independent biological mechanisms cause exercise-associated hyponatremia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci. 2005;102:18550–5.
69. McGarvey J, Thompson J, Hanna C, et al. Sensitivity and specificity of clinical signs for assessment of dehydration in endurance athletes. Br J Sports Med. 2010;44:716–9.
70. Luks AM, McIntosh SE, Grissom CK, et al. Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med. 2010;21:146–55.
71. Talbot TS, Townes DA, Wedmore IS. To air is human: altitude illness during an expedition length adventure race. Wilderness Environ Med. 2004;15:90–4.
72. Eide RP 3rd, Asplund CA. Altitude illness: update on prevention and treatment. Curr Sports Med Rep. 2012;11:124–30.
73. Maggiorini M. High altitude-induced pulmonary oedema. Cardiovasc Res. 2006;72:41–50.
74. Boyd JJ, Agazzi G, Svajda D, et al. Venomous snakebite in mountainous terrain: prevention and management. Wilderness Environ Med. 2007;18:190–202.
75. Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med. 2011;3(11):2. doi:10.1186/1471-227X-11-2.
76. Quan D. North American poisonous bites and stings. Crit Care Clin. 2012;28:633–59.
77. Bush SP, Green SM, Laack TA, et al. Pressure immobilization delays mortality and increases intracompartmental pressure after artificial intramuscular rattlesnake envenomation in a porcine model. Ann Emerg Med. 2004;44:599–604.
78. Seifert S, White J, Currie BJ. Pressure bandaging for North American snake bite? No! Clin Toxicol (Phila). 2011;49:883–5.